Boehringer Ingelheim Pharmaceuticals, Inc. Provisional
FDA Flags (2)
Class II RecallJul 2026
Boehringer Ingelheim Pharmaceuticals, Inc.
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per B
Classification: Class II
Class II RecallMar 2023
Boehringer Ingelheim Pharmaceuticals, Inc.
JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) b
Classification: Class II